skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Theres a lot of speculation this will be sold between $200-$350 US. The insiders seem to be selling. Is it just hype? alot of shares are trading. Thanks
Read Answer Asked by hal on June 22, 2015
Q: Hello Peter, overall what is your opinion of this stock as a long term hold (5years)? Has there been any news today to cause the stock to decline 6%? Thank you, Jen
Read Answer Asked by Jen on June 18, 2015
Q: Are there any plans to initiate coverage on Concordia? In the meantime thoughts on adding as larger cap more stable compliment to PHM assuming it is the only other healthcare stock in a portfolio? Unless you think one of the two smaller health care stocks covered, pli and gud would be appropriate? Cheers
Read Answer Asked by Josh on June 18, 2015
Q: Here's a snip from a proposal for the July AGM

"We are seeking to increase the number of common shares that may be issued under the current stock option plan (the
“2010 Stock Option Plan”) from 26,193,643 shares to 20% of the Company’s issued and outstanding common
shares as at the date of shareholder approval of the amended 2010 Stock Option Plan (56,407,097 based on the
number of issued and outstanding common shares as at the date hereof)"

Does that seem unusually high? Is it time to exit this?
Read Answer Asked by Gerald on June 16, 2015
Q: Your opinion on NRI? They seem to have some plans for their p2 product and wf10 trial.
Read Answer Asked by Ron on June 16, 2015
Q: Hi, I have unsuccessfully been looking to invest in Canadian healthcare via an ETF or Mutual Fund. My time line for investment is long and am looking primarily for growth. Can you name 5 quality companies in this category. Thanks in advance.
Read Answer Asked by dale on June 16, 2015
Q: I am looking at adding CPH to my portfolio. Would you suggest starting with a half position in todays market? Also I am wondering how to interpret the company's goals. For example, they are targeting $1biln cap by 2020. Based on the current number of shares (26million) that is a stock price of almost $40. Is this what management is suggesting here?
Read Answer Asked by michael on June 15, 2015
Q: I purchased Cipher Pharmaceutical during jan.'15 at $17.60/share. It is now down to $11.11/share (37% loss). The fundamentals look pretty good (e.g. forward PE of 9.56). I would appreciate if you could fill me in about why you think it has tanked so badly and what is your outlook for it?
Read Answer Asked by DAVE on June 15, 2015
Q: I have a one half position in each of PHM and CRH. According to their last quarter IFRS results PHM had an EPS loss 0.012 and CRH had an EPS profit of 0.02. I am considering selling my PHM and buying a full position in CRH.
What do you think of this strategy?

Regards
Read Answer Asked by Robert on June 12, 2015
Q: hello, a member asked if PHM was a USA corporation and was subject to "FORM 1135". you replied "yes". I contacted Dennis Wilson (corp development) at PHM & CXV, he told me PHM and CXV are both Canadian companies, WHO IS RIGHT/WRONG? and WHY? THANKS, fred
Read Answer Asked by Fred on June 12, 2015
Q: Is there any reason for the slide in the stock??
Are yo still holding it?
Read Answer Asked by Jacqueline on June 11, 2015
Q: Hi 5i:
I'm seeking your advice on my health care /biotech holdings, and I'd like to know if I should shorten the list (I tend to hold too many stocks), make any substitutions, or change relative weightings. I hold five: IBB (full position); CRH (2/3 position), and CXR, GUD and PHM, all 1/3 positions, approximately. They together comprise 11% of the stock holdings in my actively managed portfolio. Also, do you think this is a reasonable total weight for the present market? Thanks for your valuable advice.
Read Answer Asked by Roland on June 10, 2015
Q: Hello Team
Is there any red flags with the options the management keep issuing to themselves.
Thank You
Read Answer Asked by glenn on June 10, 2015
Q: This stock has lost a quarter of its value since April 20. I realize there was a financing issue, but the steady downward momentum seems to be accelerating. I know growth stocks are volatile, but 25% is a serious fall with no end in sight. Last night on BNN Eric Nuttall described PHM is wildly overpriced and likely to take a huge fall if there is a market correction. Is it time to jump ship?
Read Answer Asked by John on June 09, 2015
Q: Good Afternoon,
I just listened to the conference call from the end of April. Correct me if I'm wrong but I think I heard them say that a realistic longer term goal is now $1Bill in annual revenue? Not sure if I misheard them but they also said their EBITDA margin currently is around 60-65%? And companies like this could trade for 10-13x EBITDA? Thank-you
Read Answer Asked by Chris on June 09, 2015
Q: Hi Peter and team
With recent news from the company and no questions asked since Dec. 2013, what is your current view of it?
Gerry
Read Answer Asked by Gerry on June 09, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!